Canada Botulinum Toxin Market Size & Outlook, 2023-2030
Canada botulinum toxin market, 2018-2030 (US$M)
Related Markets
Canada botulinum toxin market highlights
- The Canada botulinum toxin market generated a revenue of USD 531.4 million in 2023 and is expected to reach USD 885.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2023 | USD 531.4 million |
| Market revenue in 2030 | USD 885.8 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, Canada accounted for 4.8% of the global botulinum toxin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. botulinum toxin market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,019.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.85% in 2023. Horizon Databook has segmented the Canada botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
According to Global News, nearly one in every five women in Canada is dissatisfied with her appearance. High healthcare expenditure and presence of advanced healthcare facilities are some of the key factors fueling the growth of botulinum toxin market in Canada.
The Canadian Association of Medical Spas and Aesthetic Surgeons (CAMACS) recognizes the need for proper guidelines due to increasing number of cosmetic procedures in nonclinical settings. The proposed guidelines classify medical spas on the basis of procedures performed into three categories: Echelon I spas, Echelon II spas, and Echelon III spas.
Botox Cosmetic is the only FDA-approved treatment for skin rejuvenation. It is, however, on the list of prescription drugs in Canada and must only be administered by a trained and licensed medical practitioner. However, stringent regulatory approval process impedes market growth in Canada.
Reasons to subscribe to Canada botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into Canada botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada botulinum toxin market size, by product, 2018-2030 (US$M)
Canada Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
